transition 
is simple
is simpleGAMMAGARD LIQUID is the result of several years of clinical research and is the latest step in Baxter's ongoing effort toward advancing the science of IVIG.
Over time many patients who currently receive IVIG infusions with GAMMAGARD S/D [Immune Globulin Intravenous (Human)] Solvent Detergent Treated may begin to receive GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)]10%.
Taking these steps can help you learn about GAMMAGARD LIQUID.
- Ask the healthcare professional who administers your GAMMAGARD S/D infusion when you may be transitioned to GAMMAGARD LIQUID
- Talk to your doctor about:
- The GAMMAGARD LIQUID formulation, with no added sugars, no added salt, no added preservatives, and latex-free packaging.1
- The GAMMAGARD LIQUID dedicated 3-step process specifically designed for viralinactivation/removal1
- Read this Letter to Patients for more information on making the transition to GAMMAGARD LIQUID. You can download and print the letter to discuss with your healthcare professional.
- Visit www.immunedisease.com for more information
- If you have questions, call Baxter Medical Affairs at 1-866-424-6724
 |
To view PDF, you will need Adobe® Acrobat® Reader® software. |
Please see Important Safety Information and Full Prescribing Information for GAMMAGARD LIQUID.